Hepatocyte growth factor increases mitochondrial mass in glioblastoma cells

Biochemical and Biophysical Research Communications

Volumn 345, Issue 4, 2006, Pages 1358-1364

  Xia, Shuli ^a   Laterra, John ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Glioblastoma; HGF; Mitochondrial mass; Mitochondrial succinate dehydrogenase; Succinate tetrazolium reductase

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 MORPHOLINO 8 PHENYLCHROMONE; CAMPTOTHECIN; SCATTER FACTOR; SUCCINATE DEHYDROGENASE; SUCCINIC ACID; TETRAZOLIUM REDUCTASE;

ARTICLE; CITRIC ACID CYCLE; CONTROLLED STUDY; DOSE RESPONSE; ENZYME ACTIVITY; EXPOSURE; FLOW CYTOMETRY; FLUORESCENCE; GLIOBLASTOMA; HUMAN; HUMAN CELL; MITOCHONDRION; PRIORITY JOURNAL; TUMOR CELL;

CAMPTOTHECIN; CELL LINE, TUMOR; DNA TOPOISOMERASES, TYPE I; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; FLAVONOIDS; FLOW CYTOMETRY; GLIOBLASTOMA; HEPATOCYTE GROWTH FACTOR; HUMANS; MAP KINASE SIGNALING SYSTEM; MITOCHONDRIA; MITOGEN-ACTIVATED PROTEIN KINASES; SUCCINATE DEHYDROGENASE; TIME FACTORS;

EID: 33744542516     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2006.05.064     Document Type: Article

References (39)

1. Bhargava M., Joseph A., Knesel J., Halaban R., Li Y., Pang S., Goldberg I., Setter E., Donovan M.A., Zarnegar R., et al. Scatter factor and hepatocyte growth factor: activities, properties, and mechanism. Cell Growth Differ. 3 (1992) 11-20
2. Bottaro D.P., Rubin J.S., Faletto D.L., Chan A.M., Kmiecik T.E., Vande Woude G.F., and Aaronson S.A. Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product. Science 251 (1991) 802-804
3. Hammond D.E., Carter S., and Clague M.J. Met receptor dynamics and signalling. Curr. Top. Microbiol. Immunol. 286 (2004) 21-44
4. Gao C.F., and Vande Woude G.F. HGF/SF-Met signaling in tumor progression. Cell Res. 15 (2005) 49-51
5. Bardelli A., Pugliese L., and Comoglio P.M. "Invasive-growth" signaling by the Met/HGF receptor: the hereditary renal carcinoma connection. Biochim. Biophys. Acta 1333 (1997) M41-M51
6. Lamszus K., Schmidt N.O., Jin L., Laterra J., Zagzag D., Way D., Witte M., Weinand M., Goldberg I.D., Westphal M., and Rosen E.M. Scatter factor promotes motility of human glioma and neuromicrovascular endothelial cells. Int. J. Cancer 75 (1998) 19-28
7. Dunsmore S.E., Rubin J.S., Kovacs S.O., Chedid M., Parks W.C., and Welgus H.G. Mechanisms of hepatocyte growth factor stimulation of keratinocyte metalloproteinase production. J. Biol. Chem. 271 (1996) 24576-24582
8. Kuroi K., and Toi M. Circulating angiogenesis regulators in cancer patients. Int. J. Biol. Markers 16 (2001) 5-26
9. Yo Y., Morishita R., Nakamura S., Tomita N., Yamamoto K., Moriguchi A., Matsumoto K., Nakamura T., Higaki J., and Ogihara T. Potential role of hepatocyte growth factor in the maintenance of renal structure: anti-apoptotic action of HGF on epithelial cells. Kidney Int. 54 (1998) 1128-1138
10. Bowers D.C., Fan S., Walter K.A., Abounader R., Williams J.A., Rosen E.M., and Laterra J. Scatter factor/hepatocyte growth factor protects against cytotoxic death in human glioblastoma via phosphatidylinositol 3-kinase- and AKT-dependent pathways. Cancer Res. 60 (2000) 4277-4283
11. Gao M., Fan S., Goldberg I.D., Laterra J., Kitsis R.N., and Rosen E.M. Hepatocyte growth factor/scatter factor blocks the mitochondrial pathway of apoptosis signaling in breast cancer cells. J. Biol. Chem. 276 (2001) 47257-47265
12. Fan S., Gao M., Meng Q., Laterra J.J., Symons M.H., Coniglio S., Pestell R.G., Goldberg I.D., and Rosen E.M. Role of NF-kappaB signaling in hepatocyte growth factor/scatter factor-mediated cell protection. Oncogene 24 (2005) 1749-1766
13. Kosai K., Matsumoto K., Nagata S., Tsujimoto Y., and Nakamura T. Abrogation of Fas-induced fulminant hepatic failure in mice by hepatocyte growth factor. Biochem. Biophys. Res. Commun. 244 (1998) 683-690
14. Arakaki N., Kajihara T., Arakaki R., Ohnishi T., Kazi J.A., Nakashima H., and Daikuhara Y. Involvement of oxidative stress in tumor cytotoxic activity of hepatocyte growth factor/scatter factor. J. Biol. Chem. 274 (1999) 13541-13546
15. Gohda E., Okauchi H., Iwao M., and Yamamoto I. Induction of apoptosis by hepatocyte growth factor/scatter factor and its augmentation by phorbol esters in Meth A cells. Biochem. Biophys. Res. Commun. 245 (1998) 278-283
16. Matteucci E., Castoldi R., and Desiderio M.A. Hepatocyte growth factor induces pro-apoptotic genes in HepG2 hepatoma but not in B16-F1 melanoma cells. J. Cell. Physiol. 186 (2001) 387-396
17. Matteucci E., Modora S., Simone M., and Desiderio M.A. Hepatocyte growth factor induces apoptosis through the extrinsic pathway in hepatoma cells: favouring role of hypoxia-inducible factor-1 deficiency. Oncogene 22 (2003) 4062-4073
18. Rasola A., Anguissola S., Ferrero N., Gramaglia D., Maffe A., Maggiora P., Comoglio P.M., and Di Renzo M.F. Hepatocyte growth factor sensitizes human ovarian carcinoma cell lines to paclitaxel and cisplatin. Cancer Res. 64 (2004) 1744-1750
19. Yuan R., Fan S., Achary M., Stewart D.M., Goldberg I.D., and Rosen E.M. Altered gene expression pattern in cultured human breast cancer cells treated with hepatocyte growth factor/scatter factor in the setting of DNA damage. Cancer Res. 61 (2001) 8022-8031
20. Abounader R., Reznik T., Colantuoni C., Martinez-Murillo F., Rosen E.M., and Laterra J. Regulation of c-Met-dependent gene expression by PTEN. Oncogene 23 (2004) 9173-9182
21. Yerushalmi G.M., Leibowitz-Amit R., Shaharabany M., and Tsarfaty I. Met-HGF/SF signal transduction induces mimp, a novel mitochondrial carrier homologue, which leads to mitochondrial depolarization. Neoplasia 4 (2002) 510-522
22. Kaplan O., Firon M., Vivi A., Navon G., and Tsarfaty I. HGF/SF activates glycolysis and oxidative phosphorylation in DA3 murine mammary cancer cells. Neoplasia 2 (2000) 365-377
23. Lai J.C.K., and Clark J.B. Isolation and characterization of synaptic and nonsynaptic mitochondria from mammalian brain. In: Boulton A.A., and Baker G.B. (Eds). Neuromethods, Carbohydrates and energy metabolism vol. 2 (1989), The Human Press, Clifton, NJ 47-62
24. Nemeth C. The liver-pathogenic role of spleen suspension of rats treated with carbon tetrachloride. Ann. Immunol. Hung. 17 (1973) 117-130
25. Hoth M., Fanger C.M., and Lewis R.S. Mitochondrial regulation of store-operated calcium signaling in T lymphocytes. J. Cell Biol. 137 (1997) 633-648
26. Scarpulla R.C. Nuclear activators and coactivators in mammalian mitochondrial biogenesis. Biochim. Biophys. Acta 1576 (2002) 1-14
27. Kelly D.P., and Scarpulla R.C. Transcriptional regulatory circuits controlling mitochondrial biogenesis and function. Genes Dev. 18 (2004) 357-368
28. Barger P.M., Browning A.C., Garner A.N., and Kelly D.P. p38 mitogen-activated protein kinase activates peroxisome proliferator-activated receptor alpha: a potential role in the cardiac metabolic stress response. J. Biol. Chem. 276 (2001) 44495-44501
29. Nisoli E., Clementi E., Paolucci C., Cozzi V., Tonello C., Sciorati C., Bracale R., Valerio A., Francolini M., Moncada S., and Carruba M.O. Mitochondrial biogenesis in mammals: the role of endogenous nitric oxide. Science 299 (2003) 896-899
30. Li F., Wang Y., Zeller K.I., Potter J.J., Wonsey D.R., O'Donnell K.A., Kim J.W., Yustein J.T., Lee L.A., and Dang C.V. Myc stimulates nuclearly encoded mitochondrial genes and mitochondrial biogenesis. Mol. Cell Biol. 25 (2005) 6225-6234
31. Kroemer G. Mitochondrial control of apoptosis: an introduction. Biochem. Biophys. Res. Commun. 304 (2003) 433-435
32. Khosravi-Far R., and Esposti M.D. Death receptor signals to mitochondria. Cancer Biol. Ther. 3 (2004) 1051-1057
33. Kaufmann S.H., and Earnshaw W.C. Induction of apoptosis by cancer chemotherapy. Exp. Cell Res. 256 (2000) 42-49
34. Kim R. Recent advances in understanding the cell death pathways activated by anticancer therapy. Cancer 103 (2005) 1551-1560
35. Mancini M., Anderson B.O., Caldwell E., Sedghinasab M., Paty P.B., and Hockenbery D.M. Mitochondrial proliferation and paradoxical membrane depolarization during terminal differentiation and apoptosis in a human colon carcinoma cell line. J. Cell Biol. 138 (1997) 449-469
36. Reipert S., Berry J., Hughes M.F., Hickman J.A., and Allen T.D. Changes of mitochondrial mass in the hemopoietic stem cell line FDCP-mix after treatment with etoposide: a correlative study by multiparameter flow cytometry and confocal and electron microscopy. Exp. Cell Res. 221 (1995) 281-288
37. Kuznetsov A.V., Janakiraman M., Margreiter R., and Troppmair J. Regulating cell survival by controlling cellular energy production: novel functions for ancient signaling pathways?. FEBS Lett. 577 (2004) 1-4
38. Dias N., and Bailly C. Drugs targeting mitochondrial functions to control tumor cell growth. Biochem. Pharmacol. 70 (2005) 1-12
39. Arakaki N., Kazi J.A., Kazihara T., Ohnishi T., and Daikuhara Y. Hepatocyte growth factor/scatter factor activates the apoptosis signaling pathway by increasing caspase-3 activity in sarcoma 180 cells. Biochem. Biophys. Res. Commun. 245 (1998) 211-215